Variant NM_000492.4:c.1210-34TG[10]


Variant details:
Name NM_000492.4:c.1210-34TG[10]
#Exon/intron intron 9
Legacy Name 1342-12(GT)n
Class non disease-causing







External sources:

Not found		dbSNP
no rs
Not found
Not found







No patient found in CFTR-NGS catalogue


78 patients carrying this variant are reported in CFTR-France:

TOTAL NUMBER OF PATIENTS 78
Asymptomatic compound heterozygote 2
CF 16
CFTR-RD56
  • Bronchiectasis  3
  • CBAVD  34
  • Other  15
  • Pancreatitis  4
Pending (NBS) 4



Detailed genotypes:
Phenotype Patient ID Variant status Additional variants
CF 1166heterozygoteCF-causing- Undef
CF-causing- Undef
CF 1157heterozygoteCF-causing- Undef
CF-causing- Undef
CF 1153heterozygoteCF-causing- Undef
CF-causing- Undef
CF 1151heterozygoteCF-causing- Undef
VUS4- Undef
CF 1128heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
varying clinical consequence- Undef
CF-causing- Undef
CF 1121heterozygoteCF-causing- Undef
CF-causing- Undef
CF 1211heterozygoteCF-causing- Undef
CF-causing- Undef
CF 4297heterozygoteCF-causing- Undef
CF-causing- Undef
CF 488heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CF 383heterozygotevarying clinical consequence- Undef
CF-causing- Undef
CF-causing- Undef
CF 745heterozygoteCF-causing- Undef
CF-causing- Undef
CF 4776heterozygotevarying clinical consequence- Undef
varying clinical consequence- Undef
CF 297heterozygoteCF-causing- Undef
CF-causing- Undef
non-CF- Undef
CF 559heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CF 637heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CF 3969homozygotec.1521_1523del - p.(Phe508del) - Trans
c.2988+1173_3468+2111del - p.(Leu997_Leu1156del) - Trans
Pending (NBS) 4549heterozygoteCF-causing- Undef
VUS2- Undef
VUS1- Undef
Pending (NBS) 2212heterozygotevarying clinical consequence- Undef
CFTR-RD-causing- Undef
Pending (NBS) 387heterozygoteCF-causing- Undef
VUS4- Undef
Pending (NBS) 726heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 1066heterozygotevarying clinical consequence- Undef
CF-causing- Undef
CBAVD 1979heterozygotevarying clinical consequence- Undef
CFTR-RD-causing- Undef
CBAVD 4543heterozygotevarying clinical consequence- Undef
VUS4- Undef
CBAVD 4531heterozygoteCF-causing- Undef
VUS1- Undef
CBAVD 4310heterozygoteCF-causing- Undef
CBAVD 4291heterozygoteVUS4- Undef
CBAVD 4264heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 1030heterozygotevarying clinical consequence- Undef
CFTR-RD-causing- Undef
CBAVD 494heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 492heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 485heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 483heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 482heterozygoteCFTR-RD-causing- Undef
CBAVD 477heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 469heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 468heterozygoteCF-causing- Undef
CBAVD 447heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 432heterozygoteCF-causing- Undef
CBAVD 425heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 412heterozygoteCF-causing- Undef
VUS4- Undef
CBAVD 411heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 407heterozygoteCFTR-RD-causing- Undef
CF-causing- Undef
CBAVD 498heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 513heterozygoteCFTR-RD-causing- Undef
CF-causing- Undef
CBAVD 679heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 687heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 712heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 774heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 678heterozygoteCFTR-RD-causing- Undef
CF-causing- Undef
CBAVD 515heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 541heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 544heterozygoteCF-causing- Undef
varying clinical consequence- Undef
CBAVD 553heterozygoteCF-causing- Undef
CFTR-RD-causing- Undef
CBAVD 589heterozygotevarying clinical consequence- Undef
CF-causing- Undef
Pancreatitis 4815heterozygoteCF-causing- Undef
CF-causing- Undef
Pancreatitis 4299heterozygotevarying clinical consequence- Undef
CF-causing- Undef
Pancreatitis 3221heterozygoteVUS1- Undef
Pancreatitis 669heterozygoteCF-causing- Undef
Other 1185heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Other 1184heterozygotevarying clinical consequence- Undef
CFTR-RD-causing- Undef
Other 1134heterozygotevarying clinical consequence- Undef
CF-causing- Undef
Other 1113heterozygoteCF-causing- Undef
varying clinical consequence- Undef
VUS1- Undef
Other 1098heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Other 1082heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Other 1073heterozygotevarying clinical consequence- Undef
CF-causing- Undef
Other 4547heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Other 4813heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Other 4812heterozygoteCF-causing- Undef
VUS3- Undef
Other 4293heterozygoteVUS1- Undef
Other 4262heterozygoteCFTR-RD-causing- Undef
CFTR-RD-causing- Undef
CF-causing- Undef
Other 1061heterozygoteVUS2- Undef
Other 4792heterozygoteCF-causing- Undef
VUS1- Undef
Other 4770heterozygoteCF-causing- Undef
VUS1- Undef
Bronchiectasis 1120heterozygotevarying clinical consequence- Undef
Bronchiectasis 1117heterozygoteCF-causing- Undef
varying clinical consequence- Undef
Bronchiectasis 1090heterozygoteCF-causing- Undef
VUS1- Undef
varying clinical consequence- Undef
Asymptomatic compound heterozygote 4235heterozygotevarying clinical consequence- Undef
CF-causing- Undef
Asymptomatic compound heterozygote 3032heterozygoteCF-causing- Undef
VUS1- Undef


Color code:   non disease-causing <   VUS1 <   VUS2 <   VUS3 <   VUS4 <   VUS5 <   disease-causing



            CFTR variants are clustered into five groups:
  • CF-causing: when in trans with another CF-causing mutation, will result in CF.
  • CFTR-RD causing: when in trans with a CF-causing mutation, will result in CFTR-related disorders (CFTR-RD) such as chronic pancreatitis, bronchiectasis, CRS-NP (chronic rhinosinusitis with or without nasal polyposis) or CBAVD (congenital absence of vas deferens), according to Bombieri C et al., 2011.
  • Varying clinical consequence: when in trans with another CF-causing mutation, can either result in CF or in a CFTR-RD.
  • Non disease-causing: when in trans with a CF-causing mutation, will not cause CF, nor CFTR-RD.
  • VUS (Variant of unknown clinical significance): unclassified because of insufficient data.



Go to CFTRare